TMDX
NASDAQ
$74.29
Transmedics Group Inc (TMDX)
TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $114 (+53.45%)
Market Cap
$2.60B
PEG Ratio
0.06
Revenue 5Y CAGR
+100.69%
P/E Ratio
15.00
Price Chart
Valuation
Market Cap$2.60B
P/E15.00
Forward P/E37.45
PEG0.06
P/S4.10
P/B5.22
Profitability
Total Revenue (TTM)$636M
Gross Profit (TTM)$376M
EBITDA$127M
Profit Margin4.2%
Operating Margin7.6%
EPS$5.02
Financial Health
Debt-to-Equity3%
Free Cash Flow Yield5.81%
Growth & Risk
Revenue 5Y CAGR+100.69%
Beta (5Y)1.21
Sharpe Ratio-0.49